Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligoarthritis, Juvenile”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Not applicableStudy completedNCT01304420
What this trial is testing

Ultrasonography in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis, OligoarthritisPolyarticular Juvenile Rheumatoid ArthritisSystemic Juvenile Idiopathic Arthritis
University of Aarhus 95
Large-scale testing (Phase 3)Looking for participantsNCT03728478
What this trial is testing

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS

Who this might be right for
Oligoarthritis, JuvenilePolyarthritis, Juvenile, Rheumatoid Factor Negative
Istituto Giannina Gaslini 260
Large-scale testing (Phase 3)Study completedNCT03031782
What this trial is testing

Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis-related Arthritis
Novartis Pharmaceuticals 86
Large-scale testing (Phase 3)Looking for participantsNCT06869551
What this trial is testing

Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic Arthritis
Bristol-Myers Squibb 60
Not applicableLooking for participantsNCT02418442
What this trial is testing

Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry

Who this might be right for
Rheumatic Joint Disease
Duke University 20,000
Large-scale testing (Phase 3)Looking for participantsNCT04804553
What this trial is testing

Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis

Who this might be right for
Active Juvenile Psoriatic Arthritis
Amgen 60
Large-scale testing (Phase 3)Looking for participantsNCT05767047
What this trial is testing

Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis

Who this might be right for
Behçet's DiseaseJuvenile Psoriatic Arthritis
Amgen 48
Large-scale testing (Phase 3)Study completedNCT01550003
What this trial is testing

Pediatric Arthritis Study of Certolizumab Pegol

Who this might be right for
Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
UCB BIOSCIENCES GmbH 193
Post-approval studies (Phase 4)Study completedNCT00443430
What this trial is testing

Trial of Early Aggressive Drug Therapy in Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Chronic PolyarthritisJuvenile Idiopathic ArthritisJuvenile Rheumatoid Arthritis
Seattle Children's Hospital 85
Large-scale testing (Phase 3)Study completedNCT03773978
What this trial is testing

Baricitinib in Participants From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 220
Early research (Phase 1)Study completedNCT05252533
What this trial is testing

Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or Psoriasis

Who this might be right for
Juvenile Psoriatic ArthritisPsoriasisArthritis, Juvenile
Janssen Research & Development, LLC 31
Not applicableStudy completedNCT05545839
What this trial is testing

Transition to Adulthood Through Coaching and Empowerment in Rheumatology

Who this might be right for
Juvenile Idiopathic ArthritisJuvenile Rheumatoid ArthritisJuvenile Dermatomyositis+4 more
McMaster University 26
Not applicableNot Yet RecruitingNCT07190053
What this trial is testing

Long Term Treatment Strategies and Effectiveness of Secukinumab in Patient With JIA Subtypes of JPsA and ERA: Study From German BIKER Registry.

Who this might be right for
Enthesitis-related Arthritis (ERA)Juvenile Psoriatic Arthritis (JPsA)
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Looking for participantsNCT06663332
What this trial is testing

A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants

Who this might be right for
Crohns DiseaseColitis, UlcerativeArthritis, Psoriatic+1 more
Janssen Research & Development, LLC 196
Large-scale testing (Phase 3)Looking for participantsNCT03773965
What this trial is testing

Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Eli Lilly and Company 190
Large-scale testing (Phase 3)Ended earlyNCT01230827
What this trial is testing

The Safety and Efficacy of CNTO 148 (Golimumab) in Children With Juvenile Idiopathic Arthritis (JIA) and Multiple Joint Involvement Who Have Poor Response to Methotrexate (GO KIDS)

Who this might be right for
Juvenile Idiopathic Arthritis
Janssen Research & Development, LLC 173
Large-scale testing (Phase 3)Active Not RecruitingNCT04527380
What this trial is testing

Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis

Who this might be right for
Juvenile Psoriatic ArthritisEnthesitis Related Arthritis
Eli Lilly and Company 101
Large-scale testing (Phase 3)Looking for participantsNCT06100744
What this trial is testing

Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab

Who this might be right for
Juvenile Psoriatic Arthritis
AbbVie 40
Early research (Phase 1)Looking for participantsNCT06751238
What this trial is testing

Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).

Who this might be right for
Juvenile Psoriatic Arthritis
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)Active Not RecruitingNCT05083182
What this trial is testing

Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis

Who this might be right for
Arthritis, Juvenile
Janssen Research & Development, LLC 48
Load More Results